TipRanks

Sarah Kathryn Rouan Insider Profile

11 Followers
Sarah Kathryn Rouan, Director at Viking Therapeutics, holds 4.39K shares in Viking Therapeutics (Ticker: VKTX), holds 18.24K shares in Navidea (Ticker: NAVBQ).
tipranks
Sarah Kathryn Rouan

Sarah Kathryn Rouan
Viking Therapeutics (VKTX)
Director

Ranked #47,675 out of 109,232 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+12.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$125K
99.42%
0.58%
A breakdown of Sarah Kathryn Rouan's holdings

Insider Roles

Viking Therapeutics
(VKTX)
Director
Navidea
(NAVBQ)
Director
Roles that Sarah Kathryn Rouan holds in companies

Most Profitable Insider Trade

Stock:
Viking Therapeutics
(VKTX)
Rating:Informative Buy
Date:Apr 02, 2025 - Apr 02, 2026
Return:+35.50%
The most profitable trade made by Sarah Kathryn Rouan

Sarah Kathryn Rouan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Viking Therapeutics
Jan 05, 2026
Director
Uninformative Buy
―
$124.59K
Navidea
Jul 07, 2021
Director
Uninformative Buy
―
$729.68
List of latest transactions for each holding click on a transaction to see Sarah Kathryn Rouan's performance on stock

Sarah Kathryn Rouan insider profile FAQ

What is the percentage of profitable transactions made by Sarah Kathryn Rouan?
The percentage of profitable transactions made by Sarah Kathryn Rouan is 50%.
    What is the average return per transaction made by Sarah Kathryn Rouan?
    The average return per transaction made by Sarah Kathryn Rouan is 12.20%.
      What stocks does Sarah Kathryn Rouan hold?
      Sarah Kathryn Rouan holds: VKTX, NAVBQ stocks.
        What was Sarah Kathryn Rouan’s latest transaction?
        Sarah Kathryn Rouan latest transaction was an Uninformative Buy of ―.
          What was Sarah Kathryn Rouan's most profitable transaction?
          Sarah Kathryn Rouan’s most profitable transaction was an Informative Buy of VKTX stock on April 2, 2025. The return on the trade was 35.50%.
            What is Sarah Kathryn Rouan's role in Viking Therapeutics?
            Sarah Kathryn Rouan's role in Viking Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.